NHS managers doubt effect of investment hike
This article was originally published in Clinica
Doubts persist among UK NHS managers regarding the levels of investment available to support the ambitious healthcare delivery targets set by the government for 2008. Almost two thirds of NHS chief executives believe that the targets cannot all be met with current funding, according to a survey by the NHS Confederation, presented at its annual conference, last week in Birmingham.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.